This inventor holds 2 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignee: Innobation Bio Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Seung Koo Kim: Innovator in Antibody Research
Introduction
Seung Koo Kim is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies and chimeric antigen receptors.
Latest Patents
Seung Koo Kim holds 2 patents that focus on innovative approaches to treating diseases mediated by B cells. His latest patents include a humanized antibody specific for CD22 and a chimeric antigen receptor using the same. These inventions aim to provide new therapeutic options for conditions related to B cells, showcasing his commitment to advancing medical science.
Career Highlights
Seung Koo Kim is currently associated with Innobation Bio Co., Ltd., where he continues to push the boundaries of antibody research. His work has garnered attention for its potential impact on cancer therapies and other B cell-related diseases.
Collaborations
Seung Koo Kim collaborates with fellow researcher Ki Tae Kim, enhancing the innovative efforts at Innobation Bio Co., Ltd. Their combined expertise contributes to the advancement of cutting-edge biotechnological solutions.
Conclusion
Seung Koo Kim's contributions to antibody research and his innovative patents position him as a key figure in the biotechnology industry. His work not only reflects his dedication to scientific advancement but also holds promise for future medical breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile